相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases
Patrick G. Northup et al.
HEPATOLOGY (2021)
Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis
Nigel Armstrong et al.
HEALTH TECHNOLOGY ASSESSMENT (2020)
A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation
Ryosuke Tateishi et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2)
Markus Peck-Radosavljevic et al.
HEPATOLOGY (2019)
AGA Clinical Practice Update: Coagulation in Cirrhosis
Jacqueline G. O'Leary et al.
GASTROENTEROLOGY (2019)
Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures
Hisashi Hidaka et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists
Kathy M. Nilles et al.
HEPATOLOGY COMMUNICATIONS (2019)
Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia
Norah Terrault et al.
GASTROENTEROLOGY (2018)
Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia
Wojciech Jurczak et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia
James B. Bussel et al.
BLOOD (2014)
Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure
Norah A. Terrault et al.
JOURNAL OF HEPATOLOGY (2014)
Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
Nezam H. Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
Incidence of Bleeding Following Invasive Procedures in Patients With Thrombocytopenia and Advanced Liver Disease
Edoardo G. Giannini et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis
Amir A. Qamar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
James B. Bussel et al.
LANCET (2009)
Thrombocytopenia associated with chronic liver disease
Nezam Afdhal et al.
JOURNAL OF HEPATOLOGY (2008)
Thrombin generation in patients with cirrhosis: The role of platelets
Armando Tripodi et al.
HEPATOLOGY (2006)
Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity
T Lisman et al.
HEPATOLOGY (2006)
分享论文
